(Press-News.org) A team of scientists has answered a long-standing question in cell biology, uncovering how the cell’s main energy currency, ATP, is transported into the endoplasmic reticulum (ER). Disrupted energy transport could affect diseases such as type 2 diabetes, cancer, and neurodegenerative disorders. The study, published in Nature, confirms that the transporter protein SLC35B1 is the key gateway for ATP entry into the ER.
The research, led by David Drew, Professor of biochemistry at Stockholm University and located at SciLifeLab, reveals the first structural and mechanistic insight into how ATP enters the endoplasmic reticulum (ER) using the transporter protein SLC35B1. The ER is the cells main “shipping port” that packages proteins and lipids, checks their quality, and facilitates their transport within the cell. For these vital processes, energy in the form of ATP, is required.
“Despite decades of research into ER function, the question of how ATP reaches the inside of the ER has been unclear. By confirming SLC35B1 as the transporter and resolving its structure with cryo-electron microscopy, we’ve not only answered a fundamental biological question, but also opened up new opportunities for therapeutic intervention”, says David Drew.
Future drug development
The findings have broad implications for human health. Disrupted ER activity is linked to diseases such as type 2 diabetes, cancer, and neurodegenerative disorders, where ER stress and protein misfolding play central roles. With a detailed molecular blueprint now available, SLC35B1 presents a promising target for future drug development.
“Understanding how energy is delivered into the ER gives us powerful new ways to tackle a range of diseases that stem from ER dysfunction. Modulating SLC35B1 activity could become a new strategy for restoring ER balance in disease states”, says David Drew.
Large scale screen
SLC35B1 has previously been proposed as an ATP transporter for the ER (Nature Comms 9:3489), but biochemical and structural validation was lacking. There have also been other, conflicting reports about its function. Teaming up with Giulio Superti-Furga Lab (CeMM, Austria), a large-scale CRISPR/Cas9 knockout screen of all SLC transporters showed that SLC35B1 was one of the five most essential transporters for cell growth, consistent with its proposed function.
Increasing protein size
An antibody against human SLC35B1 was then generated by Norimichi Nomura’s team (Kyoto Medical School, Japan), which was essential for increasing the size of the protein so it could be imaged by cryo-electron microscopy (cryo-EM). David Drew’s team then used the cryo-EM platform at SciLifeLab to visualize SLC35B1 in multiple conformations, revealing how it recognizes and transports ATP into the endoplasmic reticulum lumen. The structural data also highlighted critical amino acid residues involved in ATP binding and transport, suggesting potential sites for therapeutic targeting.
Targeted therapies
The team is currently screening for small molecules that modulate SLC35B1 function, with the goal of developing targeted therapies to either enhance or inhibit ATP transport when needed.
Find the whole study in Nature: ”Step-wise ATP translocation into the ER by human SLC35B1”
DOI: 10.1038/s41586-025-09069-w
END
Scientists reveal how energy is delivered into the cells major “shipping port”
2025-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Mind the band gap! – researchers create new nanoscale forms of elementary semiconductor with tunable electronic properties
2025-05-21
Researchers have demonstrated that by using a semiconductor with flexible bonds, the material can be moulded into various structures using nano containers, without altering its composition, the discovery could lead to the design of a variety of customised electronic devices using only a single element.
Semiconductors are vital to our daily lives, as they are found in nearly every electronic device. One of the key characteristics of semiconductors is their band gap, which determines how they conduct electric current. The band gap is typically ...
Hand2: positional code that allows axolotls to regrow limbs found
2025-05-21
Living in a murky lake around Mexico City, surrounded by aggressive and cannibalistic neighbors, the axolotl lives at constant risk of losing a limb to a neighbor’s nibble. Fortunately, lost limbs regrow and are functional in as few as eight weeks. To achieve this feat, the regrowing body parts must “know” their position within the axolotl body to regenerate the right structure for a specific location. A long-sought code that tells the cells where they are located and thereby gives body parts their identity has now been cracked by Elly Tanaka and her group at IMBA, the Institute of Molecular Biotechnology ...
Breakthrough in childhood brain cancer research reveals possible new target for therapies
2025-05-21
An international group of scientists has identified a key molecular process that drives a deadly form of childhood brain cancer, potentially offering a much-needed, new therapeutic target.
Published in leading international journal Molecular Cell, the new study has revealed how a rare but devastating childhood brain cancer—called Diffuse Midline Glioma (DMG)—hijacks the cell’s gene control machinery to fuel its growth. The findings could point the way to urgently needed new treatments for this currently incurable disease.
DMG is a tumour that develops deep in the brain and primarily ...
Scientists design gene delivery systems for cells in the brain and spinal cord
2025-05-21
Embargoed for Release
May 21, 2025
11am ET
CONTACT:
NIH Office of Communications and Public Liaison
NIHpress@nih.gov
(301) 496-5787
Scientists design gene delivery systems for cells in the brain and spinal cord
NIH-funded breakthrough could enable targeted therapies for many neurological disorders
Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are a significant step toward future precise gene therapy to ...
Lethal mutations in pregnancy loss
2025-05-21
In a study published in Nature today “Sequence diversity lost in early pregnancy,” scientists from deCODE genetics, a subsidiary of Amgen, estimate that around one in 136 pregnancies are lost due to new mutations in the fetus. In other words, millions of pregnancies worldwide are lost because of mutations every year.
The human genome varies between individuals, but there are some locations in the genome where there seems to be little or no sequence variation between individuals. This raises the question whether the sequences at these locations are essential for human development? It is known that mutations ...
Prognostic and clinicopathological significance of circPVT1 in solid tumors: a systematic review and meta-analysis
2025-05-21
Background and objectives
circPVT1 has emerged as a key regulator in disease progression and clinical outcomes. However, its prognostic relevance and association with clinicopathological parameters in solid malignancies remain to be fully elucidated. To address this, we conducted a meta-analysis to elucidate the clinical significance of circPVT1 in solid tumors.
Methods
A comprehensive literature search was conducted across multiple databases, including PubMed, Web of Science, Embase, the Cochrane Library, and CNKI, with a cutoff date of December 31, 2024. Statistical analyses were conducted using STATA 12.0 to calculate pooled hazard ratios (HRs) and ...
Leonardo da Vinci’s DNA: In new book, researchers announce breakthrough confirmation of Y chromosome shared by six living family descendants
2025-05-21
VINCI. Italy — For over five centuries, Leonardo Da Vinci has been celebrated as a visionary artist, scientist, and inventor, known for his extraordinary talent and groundbreaking experiments. Today, an international collaboration known as the Leonardo DNA Project is closer than ever to uncovering the biological secrets of the greatest genius of the Renaissance.
In their new book “Genìa Da Vinci. Genealogy and Genetics for Leonardo’s DNA,” published by Angelo Pontecorboli Editore, experts Alessandro Vezzosi and Agnese Sabato of the Leonardo Da Vinci Heritage ...
Cleveland Clinic receives $5 million grant to lead biorepository coordinating center for cystic fibrosis lung transplant consortium
2025-05-21
Wednesday, May 21, 2025, CLEVELAND: Cleveland Clinic has been awarded a $5 million grant from the Cystic Fibrosis Foundation to continue its role as the Biorepository Coordinating Center for the Cystic Fibrosis Lung Transplant Consortium until 2030. The coordinating center provides the infrastructure to support research to improve understanding of the factors that affect lung transplant outcomes.
The initiative, which includes 15 participating institutions in North America, is led by Maryam Valapour, M.D., M.P.P., director of Lung Transplant Outcomes at Cleveland Clinic, and Suzy Comhair, Ph.D., scientific director of Cleveland ...
Can plants hear their pollinators? #ASA188
2025-05-21
NEW ORLEANS, May 21, 2025 – When pollinators visit flowers, they produce a variety of characteristic sounds, from wing flapping during hovering, to landing and takeoff. However, these sounds are extremely small compared to other vibrations and acoustics of insect life, causing researchers to overlook these insects’ acoustic signals often related to wing and body buzzing.
Francesca Barbero, a professor of zoology at the University of Turin, and her collaborators — an interdisciplinary mix of entomologists, sound engineers, and plant physiologists ...
New study reveals why common leukemia treatments fail in some patients
2025-05-21
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn’t work for everyone. The findings could help doctors better match patients with the therapies most likely to work for them.
The study was published today in Blood Cancer Discovery.
Researchers analyzed data from 678 AML patients, the largest group studied to date for this treatment and found that both gene mutations and the maturity of leukemia cells affect ...